About Nucleus Formulation Private Limited
Data last updated: 25 December 2025
Nucleus Formulation Private Limited is a private limited company based in Chhatral, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 July 2009, the company has been in operation for over 17 years.
Registered with ROC Ahmedabad under CIN U24239GJ2009PTC057517.
Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Jitendra Lavjibhai Patel and Dipesh Jyotindrakumar Thakar.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 3484 Ph – 4 Gidc Chhatral Tal Kalol, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.79 Cr, a growth of 14% compared to the previous year.
The company has a workforce of approximately 13 employees as per the latest available data.
The company is associated with 1 brand - Nucleus Formulation. As per MCA filings, the company has open charges of ₹2.57 Cr and satisfied charges of ₹5.83 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nucleusformulation.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No 3484 Ph – 4 Gidc Chhatral Tal Kalol, Gujarat, India – 382729
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Nucleus Formulation Private Limited
Nucleus Formulation Private Limited operates one associated brand: Nucleus Formulation. These brands represent Nucleus Formulation Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations for therapeutic needs and exports worldwide. | nucleusformulation.com |
Competitors & Alternatives of Nucleus Formulation Private Limited
Brands and companies operating in the same space as Nucleus Formulation Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jubilant Life Sciences
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
Akums
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
Nectar Lifesciences
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Windlas
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
Unither
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
Recipharm
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
CoreRx
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
MedPharm
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Business Activity of Nucleus Formulation Private Limited
Nucleus Formulation Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Nucleus Formulation Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Nucleus Formulation Private Limited
Nucleus Formulation Private Limited is audited by BONY SHAH & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BONY SHAH & CO. | Locked | Locked | Locked |
Complete auditor history for Nucleus Formulation Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nucleus Formulation Private Limited
Nucleus Formulation Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Lavjibhai Patel | Director | 13 Jul 2009 | 17 Years 0 Months | Current |
|
Dipesh Jyotindrakumar Thakar
Also directs:
Dipjyot Global Trade Private Limited
|
Director | 13 Jul 2009 | 17 Years 0 Months | Current |
Financials of Nucleus Formulation Private Limited FY 2025 filings available
Nucleus Formulation Private Limited reported revenue of ₹5.79 Cr (up 14.00% YoY) for FY 2025.
Ten-year financial statements for Nucleus Formulation Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nucleus Formulation Private Limited
Shareholding and ownership data for Nucleus Formulation Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nucleus Formulation Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2023 | Sidbi | ₹52.6 Lakh | Open |
| 06 Jun 2023 | Others | ₹2 Cr | Open |
| 24 Jun 2021 | Hdfc Bank Limited | ₹4 Lakh | Open |
| 11 Apr 2019 | Others | ₹2.5 Cr | Satisfied |
| 09 Oct 2014 | Hdfc Bank Limited | ₹1.36 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Nucleus Formulation Private Limited
Nucleus Formulation Private Limited has a workforce of 13 employees as of Mar 06, 2025.
Employee and EPFO history for Nucleus Formulation Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nucleus Formulation Private Limited
GST registrations and filing compliance for Nucleus Formulation Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nucleus Formulation Private Limited
Credit ratings, litigation, and regulatory alerts for Nucleus Formulation Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nucleus Formulation Private Limited
MSME payment history for Nucleus Formulation Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nucleus Formulation Private Limited
Corporate group structure for Nucleus Formulation Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nucleus Formulation Private Limited
MCA filings and documents for Nucleus Formulation Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nucleus Formulation Private Limited
Frequently Asked Questions about Nucleus Formulation Private Limited
Nucleus Formulation Private Limited is an active private limited company in the pharma sector based in Chhatral, Gujarat, India. It was incorporated on 13 July 2009 (17+ years old) and is registered under CIN U24239GJ2009PTC057517. The company has 13 employees.
Nucleus Formulation Private Limited reported revenue of ₹5.79 Cr for FY 2025 (up 14.00% YoY).
The current directors of Nucleus Formulation Private Limited are:
- Jitendra Lavjibhai Patel - Director
- Dipesh Jyotindrakumar Thakar - Director
The primary industry of Nucleus Formulation Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Nucleus Formulation Private Limited can be reached at the registered office: Plot No 3484 Ph – 4 Gidc Chhatral Tal Kalol, Gujarat, India – 382729, or through the website nucleusformulation.com.
The authorised capital is ₹50 Lakh, and the paid-up capital is ₹50 Lakh.